ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,863Medicare Part D Prescriptions Filled, Including Refills

Rank: 221 out of 670

$540K Total Retail Price of All Prescriptions

Rank: 165 out of 670

377 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
41% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in West Virginia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

16% of this provider’s 377 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

4% of this provider’s 5,891 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$69 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
HYDROCODONE-ACETAMINOPHEN 435 299 S3 1 1
OMEPRAZOLE 339 305 2 5
LEVOTHYROXINE SODIUM 313 220 3 2
LISINOPRIL 265 216 4 3
SIMVASTATIN 219 168 5 4
GABAPENTIN 203 147 6 11
ATENOLOL 198 165 7 17
AMLODIPINE BESYLATE 196 166 8 7
METFORMIN HCL 165 141 9 8
PAROXETINE HCL 149 117 10 52
FUROSEMIDE 146 128 11 6
METOPROLOL TARTRATE 145 76 12 9
AMITRIPTYLINE HCL 130 118 R 13 68
POTASSIUM CHLORIDE 125 105 14 16
LOSARTAN POTASSIUM 118 99 15 26
HYDROCHLOROTHIAZIDE 116 83 16 10
WARFARIN SODIUM 94 66 17 13
PROAIR HFA 94 71 17 28
FLUTICASONE PROPIONATE 90 59 19 37
CITALOPRAM HBR 89 49 20 20
PRAVASTATIN SODIUM 86 66 21 19
PANTOPRAZOLE SODIUM 84 83 22 41
METOPROLOL SUCCINATE 78 74 23 12
TRAMADOL HCL 77 47 24 21
NEXIUM 74 28 25 14
SERTRALINE HCL 73 31 26 22
AMLODIPINE BESYLATE-BENAZEPRIL 71 64 27 74
PREDNISONE 69 44 28 40
AZITHROMYCIN 68 46 29 35
ISOSORBIDE MONONITRATE ER 67 40 30 45
ATORVASTATIN CALCIUM 67 45 30 15
LISINOPRIL-HYDROCHLOROTHIAZIDE 65 40 32 27
GLIPIZIDE XL 64 59 33 113
CLOPIDOGREL 64 49 33 24
ALENDRONATE SODIUM 63 56 35 43
CRESTOR 61 40 36 18
ZOLPIDEM TARTRATE 61 42 36 23
SINGULAIR 60 42 38 56
SYNTHROID 55 42 39 47
GLYBURIDE-METFORMIN HCL 54 44 R 40 157
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 9, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.